Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jörg Eder

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Handbook of Experimental Pharmacology|September 3, 2015
Trends in Modern Drug DiscoveryJörg Eder, Paul L Herrling
Nature Reviews. Drug Discovery|July 19, 2014
The discovery of first-in-class drugs: origins and evolutionJörg Eder, Richard Sedrani, Christian Wiesmann
Immunological Reviews|October 11, 2022
Low-molecular weight inhibitors of the alternative complement pathwayAnna Schubart, Stefanie Flohr, Tobias Junt, et al.
Journal of Molecular Biology|September 3, 2004
Crystal structure of an activation intermediate of cathepsin ENils Ostermann, Bernd Gerhartz, Susanne Worpenberg, et al.
Current Pharmaceutical Design|February 23, 2007
Aspartic proteases in drug discoveryJörg Eder, Ulrich Hommel, Frederic Cumin, et al.
Nature Reviews. Drug Discovery|July 8, 2017
Opportunities and challenges in phenotypic drug discovery: an industry perspectiveJohn G Moffat, Fabien Vincent, Jonathan A Lee, et al.
Journal of Molecular Biology|November 25, 2005
Crystal structure of human BACE2 in complex with a hydroxyethylamine transition-state inhibitorNils Ostermann, Jörg Eder, Ulf Eidhoff, et al.
Bioorganic & Medicinal Chemistry Letters|October 21, 2005
Design and preparation of 2-benzamido-pyrimidines as inhibitors of IKKRudolf Waelchli, Birgit Bollbuck, Christian Bruns, et al.
Cancer Research|June 3, 2009
Src stimulates fibroblast growth factor receptor-2 shedding by an ADAM15 splice variant linked to breast cancerThorsten Maretzky, Sylvain M Le Gall, Susanne Worpenberg-Pietruk, et al.
Biochemical and Biophysical Research Communications|February 9, 2021
Pharmacological inhibition of IKKβ dampens NLRP3 inflammasome activation after priming in the human myeloid cell line THP-1Adeline Unterreiner, Joëlle Rubert, Muriel Kauffmann, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Handbook of Experimental Pharmacology|September 3, 2015
Trends in Modern Drug DiscoveryJörg Eder, Paul L Herrling
Nature Reviews. Drug Discovery|July 19, 2014
The discovery of first-in-class drugs: origins and evolutionJörg Eder, Richard Sedrani, Christian Wiesmann
Immunological Reviews|October 11, 2022
Low-molecular weight inhibitors of the alternative complement pathwayAnna Schubart, Stefanie Flohr, Tobias Junt, et al.
Journal of Molecular Biology|September 3, 2004
Crystal structure of an activation intermediate of cathepsin ENils Ostermann, Bernd Gerhartz, Susanne Worpenberg, et al.
Current Pharmaceutical Design|February 23, 2007
Aspartic proteases in drug discoveryJörg Eder, Ulrich Hommel, Frederic Cumin, et al.
Nature Reviews. Drug Discovery|July 8, 2017
Opportunities and challenges in phenotypic drug discovery: an industry perspectiveJohn G Moffat, Fabien Vincent, Jonathan A Lee, et al.
Journal of Molecular Biology|November 25, 2005
Crystal structure of human BACE2 in complex with a hydroxyethylamine transition-state inhibitorNils Ostermann, Jörg Eder, Ulf Eidhoff, et al.
Bioorganic & Medicinal Chemistry Letters|October 21, 2005
Design and preparation of 2-benzamido-pyrimidines as inhibitors of IKKRudolf Waelchli, Birgit Bollbuck, Christian Bruns, et al.
Cancer Research|June 3, 2009
Src stimulates fibroblast growth factor receptor-2 shedding by an ADAM15 splice variant linked to breast cancerThorsten Maretzky, Sylvain M Le Gall, Susanne Worpenberg-Pietruk, et al.
Biochemical and Biophysical Research Communications|February 9, 2021
Pharmacological inhibition of IKKβ dampens NLRP3 inflammasome activation after priming in the human myeloid cell line THP-1Adeline Unterreiner, Joëlle Rubert, Muriel Kauffmann, et al.
Pageof 2